[Chronic myeloid leukemia--treatment]

Dtsch Med Wochenschr. 2002 Dec 6;127(49):2621-4. doi: 10.1055/s-2002-35948.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Adult
  • Antimetabolites, Antineoplastic / therapeutic use
  • Antineoplastic Agents / therapeutic use*
  • Benzamides
  • Cytarabine / therapeutic use
  • Enzyme Inhibitors / therapeutic use
  • Female
  • Humans
  • Hydroxyurea / therapeutic use
  • Imatinib Mesylate
  • Interferon-alpha / therapeutic use
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Male
  • Piperazines / therapeutic use
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pyrimidines / therapeutic use
  • Remission Induction
  • Risk Factors
  • Stem Cell Transplantation

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • Benzamides
  • Enzyme Inhibitors
  • Interferon-alpha
  • Piperazines
  • Pyrimidines
  • Cytarabine
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases
  • Hydroxyurea